関連する実験動画
Updated: Jun 22, 2026
07:33
In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Dpc4 (Smad4) と Apc 遺伝子の両方の複合変異マウスの腸腫瘍発生
Cell
|March 20, 1998
まとめ
DPC4 (SMAD4) 遺伝子を非活性化すると,Apc変異性腸内腫瘍の悪性進行を促進します. これは,大腸がんの発生と悪性腫瘍におけるSMAD4の役割を強調しています.
科学分野:
- 遺伝学と分子生物学について
- がん生物学 がん生物学
- 発達生物学 発達生物学について
背景:
- DPC4 (SMAD4) 遺伝子は,変形成長因子β (TGF-β) 信号伝達経路に決定的な役割を果たしています.
- DPC4やAPCのような腫瘍抑制遺伝子の変異が結腸直腸がんに関与している.
- ファミリアルアデノマトスポリポシス (FAP) は,多数の結腸直腸ポリップによって特徴づけられる遺伝性疾患で,しばしばAPC変異によって引き起こされます.
研究 の 目的:
- 大腸直腸腫瘍の進行におけるDPC4 (SMAD4) の役割を調査する.
- FAPのマウスモデルにおけるDPC4不活性化が腫瘍の悪性発症に影響するかどうかを判断する.
主な方法:
- マウスにおけるDPC4 (Smad4) のマウスホモログの不活性化.
- 同じ染色体上のDpc4とApc (delta716) の両方の変異を媒介性再結合によって持つ化合物ヘテロジゴットの生成.
- Apc ((delta716)) ヘテロジゴトと複合ヘテロジゴトにおける腸ポリプの発達と腫瘍の特徴の分析.
主要な成果:
- ホモジゴス型Dpc4変異体は胚性致死性であったが,ヘテロジゴスは明らかな異常を示さなかった.
- Dpc4とApc ((delta716) の両方とも変異を有する化合物ヘテロジゴットは,悪性腫瘍の増加の腸ポリプを発症した.
- これらの腫瘍は,Apc ((delta716)) ヘテロジゴトと比較して,強化されたストロマ細胞増殖,下粘膜内侵入,細胞異質性,および体内移植性を示した.
結論:
- DPC4 (SMAD4) 変異は,大腸直腸腫瘍の悪性進行に大きく寄与する.
- この研究は,SMAD4によって媒介されるTGF-βシグナル伝達経路が,腫瘍の攻撃性を制御する上で重要であることを強調しています.
- SMAD4をターゲットにすることで,より攻撃的な結腸直腸がんの治療戦略を提供することができます.
関連する概念動画
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...